First Time Loading...

Rxsight Inc
NASDAQ:RXST

Watchlist Manager
Rxsight Inc Logo
Rxsight Inc
NASDAQ:RXST
Watchlist
Price: 52.84 USD -3.79% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

RXST's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. [ Read More ]

The intrinsic value of one RXST stock under the Base Case scenario is 14.29 USD. Compared to the current market price of 52.84 USD, Rxsight Inc is Overvalued by 73%.

Key Points:
RXST Intrinsic Value
Base Case
14.29 USD
Overvaluation 73%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Rxsight Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RXST stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Rxsight Inc

Provide an overview of the primary business activities
of Rxsight Inc.

What unique competitive advantages
does Rxsight Inc hold over its rivals?

What risks and challenges
does Rxsight Inc face in the near future?

Has there been any significant insider trading activity
in Rxsight Inc recently?

Summarize the latest earnings call
of Rxsight Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Rxsight Inc.

Provide P/S
for Rxsight Inc.

Provide P/E
for Rxsight Inc.

Provide P/OCF
for Rxsight Inc.

Provide P/FCFE
for Rxsight Inc.

Provide P/B
for Rxsight Inc.

Provide EV/S
for Rxsight Inc.

Provide EV/GP
for Rxsight Inc.

Provide EV/EBITDA
for Rxsight Inc.

Provide EV/EBIT
for Rxsight Inc.

Provide EV/OCF
for Rxsight Inc.

Provide EV/FCFF
for Rxsight Inc.

Provide EV/IC
for Rxsight Inc.

Show me price targets
for Rxsight Inc made by professional analysts.

What are the Revenue projections
for Rxsight Inc?

How accurate were the past Revenue estimates
for Rxsight Inc?

What are the Net Income projections
for Rxsight Inc?

How accurate were the past Net Income estimates
for Rxsight Inc?

What are the EPS projections
for Rxsight Inc?

How accurate were the past EPS estimates
for Rxsight Inc?

What are the EBIT projections
for Rxsight Inc?

How accurate were the past EBIT estimates
for Rxsight Inc?

Compare the revenue forecasts
for Rxsight Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Rxsight Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Rxsight Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Rxsight Inc compared to its peers.

Compare the P/E ratios
of Rxsight Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Rxsight Inc with its peers.

Analyze the financial leverage
of Rxsight Inc compared to its main competitors.

Show all profitability ratios
for Rxsight Inc.

Provide ROE
for Rxsight Inc.

Provide ROA
for Rxsight Inc.

Provide ROIC
for Rxsight Inc.

Provide ROCE
for Rxsight Inc.

Provide Gross Margin
for Rxsight Inc.

Provide Operating Margin
for Rxsight Inc.

Provide Net Margin
for Rxsight Inc.

Provide FCF Margin
for Rxsight Inc.

Show all solvency ratios
for Rxsight Inc.

Provide D/E Ratio
for Rxsight Inc.

Provide D/A Ratio
for Rxsight Inc.

Provide Interest Coverage Ratio
for Rxsight Inc.

Provide Altman Z-Score Ratio
for Rxsight Inc.

Provide Quick Ratio
for Rxsight Inc.

Provide Current Ratio
for Rxsight Inc.

Provide Cash Ratio
for Rxsight Inc.

What is the historical Revenue growth
over the last 5 years for Rxsight Inc?

What is the historical Net Income growth
over the last 5 years for Rxsight Inc?

What is the current Free Cash Flow
of Rxsight Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Rxsight Inc.

Financials

Balance Sheet Decomposition
Rxsight Inc

Current Assets 168.4m
Cash & Short-Term Investments 127.2m
Receivables 20.3m
Other Current Assets 20.9m
Non-Current Assets 14.1m
PP&E 13.3m
Other Non-Current Assets 858k
Current Liabilities 20.9m
Accounts Payable 3.9m
Accrued Liabilities 17m
Other Current Liabilities 37k
Non-Current Liabilities 1.3m
Long-Term Debt 118k
Other Non-Current Liabilities 1.2m
Efficiency

Earnings Waterfall
Rxsight Inc

Revenue
89.1m USD
Cost of Revenue
-35.3m USD
Gross Profit
53.8m USD
Operating Expenses
-103.9m USD
Operating Income
-50.1m USD
Other Expenses
1.5m USD
Net Income
-48.6m USD

Free Cash Flow Analysis
Rxsight Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

RXST Profitability Score
Profitability Due Diligence

Rxsight Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Positive Gross Profit
30/100
Profitability
Score

Rxsight Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

RXST Solvency Score
Solvency Due Diligence

Rxsight Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Rxsight Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RXST Price Targets Summary
Rxsight Inc

Wall Street analysts forecast RXST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXST is 63.97 USD with a low forecast of 61.61 USD and a high forecast of 68.25 USD.

Lowest
Price Target
61.61 USD
17% Upside
Average
Price Target
63.97 USD
21% Upside
Highest
Price Target
68.25 USD
29% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

RXST Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

RXST Price
Rxsight Inc

1M 1M
+8%
6M 6M
+137%
1Y 1Y
+204%
3Y 3Y
+230%
5Y 5Y
+230%
10Y 10Y
+230%
Annual Price Range
52.84
52w Low
17.37
52w High
57.92
Price Metrics
Average Annual Return -8.2%
Standard Deviation of Annual Returns 29.69%
Max Drawdown -48%
Shares Statistics
Market Capitalization 1.9B USD
Shares Outstanding 36 987 600
Percentage of Shares Shorted 4.14%

RXST Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Rxsight Inc Logo
Rxsight Inc

Country

United States of America

Industry

Health Care

Market Cap

1.9B USD

Dividend Yield

0%

Description

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 87 full-time employees. The company went IPO on 2021-07-30. The firm is engaged in improving the vision of patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system), comprised of its RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Its LAL is made of photosensitive material that changes shape in response to patterns of ultraviolet (UV) light generated by its LDD. Its RxSight system helps surgeon to performs a standard cataract procedure to implant the LAL, and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes. Alternative IOL technologies, are not adjustable following the surgery and therefore require patients to make pre-operative choices about their visual preferences.

Contact

CALIFORNIA
Aliso Viejo
100 Columbia Street, Suite 120
+19495217822.0
https://www.rxsight.com/

IPO

2021-07-30

Employees

87

Officers

President, CEO & Director
Dr. Ronald M. Kurtz M.D.
Chief Financial Officer
Ms. Shelley B. Thunen
Chief Operating Officer
Dr. Ilya Goldshleger Ph.D.
Chief Commercial Officer
Mr. Eric J. Weinberg
Vice President of Accounting & Finance
Ms. Rebecca Williston
Chief Technology Officer
Mr. Matt Haller Ph.D.
Show More
Investor Relations
Alex Huang
Vice President of Marketing
Mr. Roy Freeman
Vice President of Human Resources
Ms. Caroline Vaughn
Senior VP of Commercial Operations & Business Process
Mr. Scott Gaines
Show Less

See Also

Discover More
What is the Intrinsic Value of one RXST stock?

The intrinsic value of one RXST stock under the Base Case scenario is 14.29 USD.

Is RXST stock undervalued or overvalued?

Compared to the current market price of 52.84 USD, Rxsight Inc is Overvalued by 73%.